AGM/EGM6 Jul 2026, 07:00 pm
Sun Pharma Announces 34th AGM on July 31, 2026
AI Summary
Sun Pharmaceutical Industries Ltd has announced its 34th Annual General Meeting (AGM) scheduled for Friday, July 31, 2026, at 04:00 P.M. IST, to be conducted through videoconferencing. The company has also released its Annual Report for the Financial Year 2025-26. Key dates for shareholders include a cut-off date of Friday, July 24, 2026, for voting eligibility, with remote e-voting commencing on Monday, July 27, 2026, and concluding on Thursday, July 30, 2026. The Annual Report highlights the company's evolution as a globally diversified pharmaceutical entity, with its Innovative Medicines business contributing 22% of consolidated sales.
Key Highlights
- 34th AGM scheduled for July 31, 2026, via videoconferencing.
- Annual Report for FY 2025-26 released.
- Remote e-voting period: July 27 - July 30, 2026.
- Innovative Medicines business contributed 22% of consolidated sales.
- Acquisition of Organon to expand global footprint and Women's Health portfolio.
Price Impact
More from SUNPHARMA